ConductScience.org, home

Gene · 25913

NIH grants1,830

NIH grants whose papers are about the gene, through NIH's grant-paper links.

861 to 880 of 1,830

Download this page as JSON
GrantTitlePOT1 papersNewest fiscal year
F32CA213742Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities12018
F32GM119190Identifying Biomolecular Networks Driving Metabolic Trait Variation12018
K02AG045339Amelioration of aged endothelial dysfunction by NAMPT and caloric restriction12018
K07CA190673Lifestyle, genetics and colonoscopy for colorectal cancer prevention12018
K99AG056679Assessing cellular aging in old and rejuvenated neurons from Alzheimer patients12018
K99GM124463Towards an understanding of telomere end protection: Cryo-EM studies of shelterin structure and function12018
P01CA080111Mechanisms of Breast Development and Carcinogenesis12018
P01GM105473Mutations Arising During DNA Repair12018
P30EB009998Case Center for Synchrotron Bioscience12018
P50AG005131UCSD Alzheimer's Disease Research Center P5012018
P50AG005134Massachusetts Alzheimer's Disease Research Center12018
P50AG016574Mayo Alzheimer's Disease Research Center12018
P50AG023501New Approaches to Dementia Heterogeneity12018
P50AG033514Molecular Imaging IN The Wisconsin ADRC12018
P50CA091846SPORE in Genitourinary Cancer12018
P50CA121973SPORE in Skin Cancer12018
P50GM082250HARC Center: HIV Accessory and Regulatory Complexes12018
R01AR064786Dermal fibroblast/ATF3 control of skin homeostasis12018
R01CA136895Understanding the context-dependent roles of mutations in lymphoma.12018
R01CA174746Promotion of tumor invasion and pseudosenescence by the aging microenvironment12018

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/25913/grants?page=44